A couple weeks ago, we revisited the topic of the Integrated Delivery Network (IDN) and how this model is once again gaining momentum in the healthcare industry. In a recent webinar by Healthcare Research & Analytics, this topic was explored more thoroughly; the presentation is now available online.
A couple weeks ago, we revisited the topic of the Integrated Delivery Network (IDN) and how this model is once again gaining momentum in the healthcare industry. In a recent webinar by Healthcare Research & Analytics, this topic was explored more thoroughly; the presentation is now available online.
Integration. Coordination of care. Reform. How will these key market changes impact your business, and, perhaps more importantly, the healthcare industry as a whole?
The following webinar was presented by Healthcare Research & Analytics and discusses this topic at length. In particular, viewers will learn:
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More